Nitrous oxide - better known as "laughing gas" - could offer fast, short-term relief for people living with severe or treatment-resistant depression, according to a major analysis led by the University of Birmingham in the United Kingdom.
The review brings together the most robust clinical data available so far on how medically administered nitrous oxide (N₂O) affects adults with major depressive disorder (MDD) and treatment-resistant depression (TRD).
